Small Interfering RNA-mediated Selective Knockdown of Postsynaptic Density Protein 95 Reverses Mechanical Allodynia in Neuropathic Pain Rats
-
摘要:
目的 评估小干扰RNA(small interfering RNA, siRNA)对突触后致密物蛋白质95(postsynaptic density protein 95, PSD-95)基因的沉默效率及PSD-95基因沉默对谷氨酸诱导的神经细胞毒性与信号转导的影响, 观察用RNA干扰(RNA interference, RNAi)技术沉默大鼠脊髓PSD-95基因治疗神经病理性疼痛的效果。 方法 用神经母细胞瘤/大鼠神经胶质细胞瘤杂交瘤细胞(NG108-15细胞)筛选大鼠PSD-95基因特异的siRNA, 并用谷氨酸刺激PSD-95基因沉默的NG108-15细胞, 检测细胞生长活力与信号通路蛋白质表达与磷酸化的改变。建立大鼠神经病理性疼痛的坐骨神经慢性压迫(chronic constriction injury, CCI)模型, 预防性及治疗性鞘内给予PSD-95siRNA, 留取脊髓标本, 实时定量PCR(real-time PCR, RT-PCR)分析PSD-95 mRNA表达水平, 并测定大鼠后足机械痛阈及热痛阈的变化。 结果 序列特异性最高的siRNA在最佳转染条件下使PSD-95基因表达水平下降91.5%;PSD-95基因沉默既可增强神经细胞对谷氨酸毒性的耐受能力, 又可抑制Ca2+/钙调蛋白依赖的蛋白质激酶Ⅱα(CaMKIIα)异构型磷酸化。正常大鼠鞘内注射PSD-95 siRNA可降低大鼠脊髓背角PSD-95 mRNA的表达水平38%(P < 0.05), 但对痛阈无显著影响; CCI模型大鼠鞘内注射PSD-95 siRNA可明显缓解神经病理性疼痛。 结论 PSD-95基因在神经病理性疼痛的发生中起重要作用。鞘内注射PSD-95 siRNA可以显著缓解CCI模型大鼠机械性和热痛觉过敏, PSD-95 siRNA可能成为有效控制神经病理性疼痛的基因治疗方法。 -
关键词:
- 神经病理性疼痛 /
- 突触后致密物蛋白质95 /
- 谷氨酸兴奋性中毒 /
- Ca2+/钙调蛋白依赖的蛋白质激酶Ⅱα /
- 慢性压迫损伤 /
- 小干扰RNA
Abstract:Objective Postsynaptic density protein 95 (PSD-95) gene specific siRNAs were introduced in vitro or in vivo to determine its succedent influence on neuropathic pain relief, neuron viability and postsynaptic calcium/calmodulin-dependent protein kinase Ⅱ (CaMKII) phosphorylation. Methods siRNAs of rat PSD-95 gene were synthesized for in vitro transfection into NG108-15 neuronal cells. The siRNA to PSD-95, or a mismatch RNA, was mixed with the transfection reagent, i-FectTM (vehicle), and delivered as repeated daily bolus doses (2 μg) via implanted intrathecal catheter to the lumbar spinal cord of rats which received chronic constriction injury (CCI) of sciatic nerve. Both mechanical allodynia and thermal hyperalgesia were measured on the post-operative day 3 and 7. PSD95 gene silenced NG108-15 cells were further stimulated by glutamate, with either the cell viability or the expression and phosphorylation of CaMKIIα to be assayed. Results The siRNAs suppressed PSD-95 gene expression level by 91.5% under the appropriate condition in vitro. High level glutamate induced neurotoxicity, which was partially eliminated by PSD-95 gene silencing. Glutamate also induced the postsynaptic expression and phosphorylation of CaMKIIα. PSD-95 siRNA injected intrathecally in normal rats lowered the expression level of PSD-95 mRNA at cornu dorsale medullae spinalis by 38% (P < 0.05) but had no remarkable effect on the pain threshold. Intrathecal injection of PSD-95 siRNA remarkably alleviated neuropathic pain. Conclusions PSD-95 gene plays an important role in the development of neuropathic pain. Intrathecal injection of PSD-95 siRNA can remarkably alleviate mechanical and thermal hyperalgesia. PSD-95 siRNA may be a promising gene therapy for neuropathic pain. -
图 2 总CaMKIIα及磷酸化CaMKIIα Western blot分析
N:阴性对照; 与阴性对照比较,†P<0. 05;与siR-N比较,‡P<0. 05;与APV比较,* P<0. 05
siR-N:同图 1图 3 PSD-95基因沉默对CCI大鼠机械和热痛觉过敏的影响
siR-N、siR-P:同图 1; 与非siR-P组比较,* P<0. 05
-
[1] Campbell JN, Meyer RA. Mechanisms of neuropathic pain[J]. Neuron, 2006, 52:77-92. doi: 10.1016/j.neuron.2006.09.021 [2] Latremoliere A, Woolf CJ. Central sensitization:a generator of pain hypersensitivity by central neural plasticity[J]. J Pain, 2009, 10:895-926. doi: 10.1016/j.jpain.2009.06.012 [3] Garry EM, Moss A, Delaney A, et al. Neuropathic sensitization of behavioral reflexes and spinal NMDA receptor/CaM kinase Ⅱ interactions are disrupted in PSD-95 mutant mice[J]. Curr Biol, 2003, 13:321-328. doi: 10.1016/S0960-9822(03)00084-8 [4] Tao F, Tao YX, Mao P, et al. Role of postsynaptic density protein-95 in the maintenance of peripheral nerve injury-induced neuropathic pain in rats[J]. Neuroscience, 2003, 117:731-739. doi: 10.1016/S0306-4522(02)00801-1 [5] Martinez J, Patkaniowska A, Urlaub H, et al. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi[J]. Cell, 2002, 110:563-574. doi: 10.1016/S0092-8674(02)00908-X [6] Størkson RV, Kjørsvik A, Tjølsen A, et al. Lumbar catheterization of the spinal subarachnoid space in the rat[J]. J Neurosci Methods, 1996, 65:167-172. doi: 10.1016/0165-0270(95)00164-6 [7] Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorder of pain sensation like those seen in man[J]. Pain, 1988, 33:87-107. doi: 10.1016/0304-3959(88)90209-6 [8] Beas-Zarate C, Rivera-Huizar SV, Martinez-Contreras A, et al. Changes in NMDA-receptor gene expression are associated with neurotoxicity induced neonatally by glutamate in the rat brain[J]. Neurochem Int, 2001, 39:1-10. doi: 10.1016/S0197-0186(01)00008-0 [9] Wang H, Yu SW, Koh DW, et al. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered exci-totoxic neuronal death[J]. J Neurosci, 2004, 24:10963-10973. doi: 10.1523/JNEUROSCI.3461-04.2004 [10] Hou XY, Zhang GY, Wang DG, et al. Suppression of postsynaptic density protein 95 by antisense oligonucleotides diminishes postischemic pyramidal cell death in rat hippocampal CA1 subfield[J]. Neurosci Lett, 2005, 385:230-233. doi: 10.1016/j.neulet.2005.05.054 [11] Franks KM, Sejnowski TJ. Complexity of calcium signaling in synaptic spines[J]. Bioessays, 2002, 24:1130-1144. doi: 10.1002/bies.10193 [12] Katano T, Nakazawa T, Nakatsuka T, et al. Involvement of spinal phosphorylation cascade of Tyr1472-NR2B, Thr286-CaMKII, and Ser831-GluR1 in neuropathic pain[J]. Neuropharmacology, 2011, 60:609-616. doi: 10.1016/j.neuropharm.2010.12.005 [13] Matsumura S, Kunori S, Mabuchi T, et al. Impairment of CaMKII activation and attenuation of neuropathic pain in mice lacking NR2B phosphorylated at Tyr1472[J]. Eur J Neurosci, 2010, 32:798-810. doi: 10.1111/j.1460-9568.2010.07348.x [14] Gabra BH, Kessler FK, Ritter JK, et al. Decrease in Nmethyl-D-aspartic acid receptor-NR2B subunit levels by intrathecal short-hairpin RNA blocks group I metabotropic glutamate receptor-mediated hyperalgesia[J]. JPET, 2007, 322:186-194. doi: 10.1124/jpet.107.120071 [15] Luo MC, Zhang DQ, Ma SW, et al. An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons[J]. Molecular Pain, 2005, 1:29. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=Doaj000001092593 [16] Christoph T, Gruānweller A, Mika J, et al. Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo[J]. Bioch Biophysical Res Communications, 2006, 350:238-243. doi: 10.1016/j.bbrc.2006.09.037 [17] Dong XW, Goregoaker A, Engler H, et al. Small interfering RNA-mediated selective knockdown of NaV1.8 tetrodotoxin-resistant sodium channel reverse mechanical allodynia in neuropathic rats[J]. Neuroscience, 2007, 146:812-821. doi: 10.1016/j.neuroscience.2007.01.054 [18] Altier C, Dale CS, Kisilevsky AE, et al. Differential role of N-type calcium channel splice isoforms in pain[J]. J Neurosci, 2007, 27:6363-6373. doi: 10.1523/JNEUROSCI.0307-07.2007 [19] Doré-Savardl L, Roussy G, Dansereau MA, et al. Central delivery of dicer-substrate siRNA:a direct application for pain research[J]. Mol Ther, 2008, 16:1331-1339. doi: 10.1038/mt.2008.98 [20] Wu FX, Bian JJ, Miao XR, et al. Intrathecal siRNA against Toll-like receptor 4 reduces nociception in a rat model of neuropathic pain[J]. Int J Med Sci, 2010, 7:251-259. http://europepmc.org/articles/PMC2920570/ [21] Tumati S, Milnes TL, Yamamura HI, et al. Intrathecal Raf-1-selective siRNA attenuates sustained morphine-mediated thermal hyperalgesia[J]. Eur J Pharmacol, 2008, 601:207-208. doi: 10.1016/j.ejphar.2008.10.033 [22] Tao F, Tao YX, Gonzalez JA, et al. Knockdown of PSD-95/SAP90 delays the development of neuropathic pain in rats[J]. Neuroreport, 2001, 12:3251-3255. doi: 10.1097/00001756-200110290-00022